Drug Reference

Mirdametinib

Mitogen-activated protein kinase (MEK) inhibitors

← All medicines · Mitogen-activated protein kinase (MEK) inhibitors

Fact box

Therapeutic class
Mitogen-activated protein kinase (MEK) inhibitors
Action class
Kinase Inhibitor
Mechanism
Mitogen-Activated Protein Kinase Kinase 1 Inhibitors
Habit forming
No

Brand names

Gomekli

Available as

1 MG · Oral Capsule2 MG · Oral Capsule1 MG · Oral Suspension

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

6 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.